Jessica Hopfield

CIK: 0001648715

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (22.2%)

Position reduction

Option Exercises (M)2 (22.2%)

Derivative conversions

Awards (A)5 (55.6%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

EDIT

Editas Medicine, Inc.

Director

PODD

INSULET CORP

Director

MRVI

MARAVAI LIFESCIENCES HOLDINGS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (9 total)

EDIT
Editas Medicine, Inc.
Jun 17, 2026
Award(A)
Stock Option (right to buy)
Direct
51.7K shares-
PODD
INSULET CORP
May 20, 2026
Award(A)
Direct
1.7K shares-
MRVI
MARAVAI LIFESCIENCES HOLDINGS, INC.
Jun 16, 2025
Award(A)
Direct
89.1K shares at avg. $2.16$193K
EDIT
Editas Medicine, Inc.
Jun 6, 2025
Award(A)
Stock Option (right to buy)
Direct
37.5K shares-
PODD
INSULET CORP
May 22, 2025
Award(A)
Direct
778 shares-
PODD
INSULET CORP
May 13, 2025
Exercise(M)
Direct
5.2K shares at avg. $28.87$151K
PODD
INSULET CORP
May 13, 2025
Sale(S)
Direct
5.2K shares at avg. $317.54$1.7M
PODD
INSULET CORP
Sep 11, 2024
Exercise(M)
Direct
7.6K shares at avg. $29.87$228K
PODD
INSULET CORP
Sep 11, 2024
Sale(S)
Direct
7.6K shares at avg. $225.26$1.7M

		Type	Shares	Price		Ownership
Jun 17, 2026	EDIT Editas Medicine, Inc.	Award(A) Stock Option (right to buy)	51,700	-	-	Direct
May 20, 2026	PODD INSULET CORP	Award(A)	1,660	-	$0	Direct
Jun 16, 2025	MRVI MARAVAI LIFESCIENCES HOLDINGS, INC.	Award(A)	89,139	$2.16	$192,540	Direct
Jun 6, 2025	EDIT Editas Medicine, Inc.	Award(A) Stock Option (right to buy)	37,500	-	-	Direct
May 22, 2025	PODD INSULET CORP	Award(A)	778	-	-	Direct
May 13, 2025	PODD INSULET CORP	Exercise(M)	5,235	$28.87	$151,134	Direct
May 13, 2025	PODD INSULET CORP	Sale(S)	5,235	$317.54	$1,662,322	Direct
Sep 11, 2024	PODD INSULET CORP	Exercise(M)	7,628	$29.87	$227,848	Direct
Sep 11, 2024	PODD INSULET CORP	Sale(S)	7,628	$225.26	$1,718,283	Direct

1-9 of 9 transactions

About Hopfield Jessica

Hopfield Jessica (SEC CIK 0001648715) files insider reports with the SEC as Director of Editas Medicine, Inc. (EDIT), Director of INSULET CORP (PODD) and Director of MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI).

Signal8 holds 7 ownership filings by Hopfield Jessica, all Form 4s, filed between Sep 12, 2024 and Jun 22, 2026. Those filings report 9 transactions, from Sep 11, 2024 to Jun 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Hopfield Jessica's filings is in CAMBRIDGE, MA.

Recent filings by Hopfield Jessica

Jun 17, 2026: Grant or award of EDIT derivative securities (Form 4, code A).
May 20, 2026: Grant or award of PODD shares (Form 4, code A).
Jun 16, 2025: Grant or award of MRVI shares (Form 4, code A).
Jun 6, 2025: Grant or award of EDIT derivative securities (Form 4, code A).
May 22, 2025: Grant or award of PODD shares (Form 4, code A).

Other insiders filing for Editas Medicine, Inc. (EDIT)

Ory Daniel Scott, EVP, Chief Medical Officer
Burkly Linda, EVP, CHIEF SCIENTIFIC OFFICER
Parison Amy, SVP, Chief Financial Officer
O'Neill Gilmore Neil, CEO
Ellinor Patrick Thomas II, Director
Connaughton Bernadette, Director

How to read Form 4 transaction codes